Author

Thomas Matthes

Primary ORCID profile (0000-0002-4875-2477 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Thomas MatthesiD2 papers · University Hospital of Geneva

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Ambra Sartori· 1 shared Christelle BoreliD· 1 shared Emilie Falconnet· 1 shared Jean-Pierre Aubry-Lachainaye· 1 shared Mitchell P. Levesque· 1 shared Pascale RibauxiD· 1 shared Phil Cheng· 1 shared Stylianos E. AntonarakisiD· 1 shared

Activity by Year

2017-2017 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ambra Sartori

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Improving Leukemic CD34+/CD38- Blasts Characterization With Single-Cell Transcriptome Sequencing

Ambra Sartori, Phil Cheng, Emilie Falconnet, Pascale Ribaux, Jean-Pierre Aubry-Lachainaye, Mitchell P. Levesque, Stylianos E. Antonarakis, Thomas Matthes, Christelle Borel

The paper uses single-cell RNA sequencing to analyze leukemic CD34+/CD38- blasts from AML patients, identifying transcriptomic features of self-renewal, mutation effects, and prognostic gene signatures.

bioRxiv · May 31, 2017 · PreprintCancer Biology